C. Hernández-Rocha

发表

JAK–STAT pathway targeting for the treatment of inflammatory bowel disease

S. Vermeire, A. Salas, D. McGovern, 2020, Nature Reviews Gastroenterology & Hepatology.

Serum cytokeratin-18 fragment levels as noninvasive marker of nonalcoholic steatohepatitis in the chilean population.

C. Benítez, M. Arrese, A. Soza, 2017, Gastroenterologia y hepatologia.

Validation study of systems for noninvasive diagnosis of fibrosis in nonalcoholic fatty liver disease in Latin population.

N. Chavez-Tapia, M. Uribe, C. Benítez, 2013, Annals of hepatology.

Zoo notic Pathogens among White-Tailed Deer , Northern Mexico , 2004 – 2009

D. Paredes-Sabja, M. Sarker, S. Bueno, 2019 .

Ethnicity influences phenotype and clinical outcomes: Comparing a South American with a North American inflammatory bowel disease cohort.

D. Alvares, J. Rivera-Nieves, M. Álvarez-Lobos, 2022, Medicine.

JAK inhibitors: current position in treatment strategies for use in inflammatory bowel disease.

N. Vande Casteele, C. Hernández-Rocha, 2020, Current opinion in pharmacology.

Outcome of relapsing Clostridium difficile infections do not correlate with virulence-, spore- and vegetative cell-associated phenotypes.

D. Paredes-Sabja, I. Calderón, F. Gil, 2015, Anaerobe.

Predominance of Clostridium difficile ribotypes 012, 027 and 046 in a university hospital in Chile, 2012

D. Paredes-Sabja, M. Wilcox, Á. Plaza-Garrido, 2015, Epidemiology and Infection.

Altered gut microbiome composition and function are associated with gut barrier dysfunction in healthy relatives of patients with Crohn's disease.

P. Moayyedi, A. Griffiths, A. Steinhart, 2022, Gastroenterology.

Prospective comparison of a commercial multiplex real-time polymerase chain reaction and an enzyme immunoassay with toxigenic culture in the diagnosis of Clostridium difficile-associated infections.

D. Paredes-Sabja, M. Álvarez-Lobos, J. Barra-Carrasco, 2013, Diagnostic microbiology and infectious disease.

Diagnostic accuracy of a multiplex real-time PCR to predict Clostridium difficile ribotype 027.

D. Paredes-Sabja, M. Álvarez-Lobos, J. Barra-Carrasco, 2013, Anaerobe.

Epidemic Clostridium difficile Ribotype 027 in Chile

D. Paredes-Sabja, M. Sarker, S. Bueno, 2012, Emerging infectious diseases.

[Management of severe ulcerative colitis: An up-to-date].

J. Miquel, J. Chianale, J. Klaassen, 2017, Revista medica de Chile.

Validation of the Simplified Criteria for the Diagnosis of Autoimmune Hepatitis in Chilean-Hispanic Patients.

C. Benítez, M. Arrese, A. Soza, 2017, Annals of hepatology.

257 – Higher Abundance of Bile Acid-Metabolizing Microbiota is Associated with Type of Disease, Biopsy Location and Mucosal Inflammation in Inflammatory Bowel Disease Patients

M. Silverberg, W. Turpin, R. Milgrom, 2019, Gastroenterology.

A role for CXCR3 ligands as biomarkers of post-operative Crohn's disease recurrence.

J. Rioux, M. Silverberg, R. Duerr, 2021, Journal of Crohn's & colitis.

[Clostridium difficile spores and its relevance in the persistence and transmission of the infection].

D. Paredes-Sabja, M. Álvarez-Lobos, Cristian Hernández-Rocha, 2014, Revista chilena de infectologia : organo oficial de la Sociedad Chilena de Infectologia.

Atypical presentation of pseudomembranous colitis localized in adenomatous polyps.

D. Paredes-Sabja, M. Álvarez-Lobos, C. Hernández-Rocha, 2013, World journal of gastroenterology.

Amerindian ancestry proportion as a risk factor for inflammatory bowel diseases: results from a Latin American Andean cohort

L. Azócar, E. Villablanca, M. Álvarez-Lobos, 2023, Frontiers in medicine.